![Tristan Peitz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tristan Peitz
No más puestos en curso
Historial de carrera de Tristan Peitz
Antiguos cargos conocidos de Tristan Peitz.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
QSAM BIOSCIENCES, INC. | Director/Miembro de la Junta | 01/05/2017 | 09/12/2020 |
Independent Dir/Board Member | 01/05/2017 | 09/12/2020 | |
Cohen Capital Management, Inc. (California)
![]() Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals. | Portfolio Manager-Fixed Income | 01/05/2010 | 01/07/2019 |
Trading-Fixed Income | 01/05/2010 | 01/07/2019 |
Formación de Tristan Peitz.
Stephen M. Ross School of Business | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 4 |
Operativa
Portfolio Manager-Fixed Income | 1 |
Trading-Fixed Income | 1 |
Director/Board Member | 1 |
Sectorial
Finance | 2 |
Process Industries | 2 |
Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Cohen Capital Management, Inc. (California)
![]() Cohen Capital Management, Inc. (California) Investment ManagersFinance Cohen Capital Management, Inc. (CCM) is a registered independent wealth management firm headquartered in Corte Madera, California. The firm was founded by Jay A. Cohen in 1995. CCM manages clients’ cash balances, equity and fixed income portfolios on a fully disclosed basis primarily for high net-worth individuals. | Finance |
QSAM Biosciences, Inc.
![]() QSAM Biosciences, Inc. Chemicals: AgriculturalProcess Industries QSAM Biosciences, Inc. engages in the provision of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, Samarium-153-DOTMP or CycloSam. The company was founded by Christopher M. Nelson, Douglas R. Baum and C. Richard Piazza on August 26, 2004 and is headquartered in Austin, TX. | Process Industries |
- Bolsa de valores
- Insiders
- Tristan Peitz
- Experiencia